Incidence and risk factors for leptomeningeal carcinomatosis in breast cancer patients with parenchymal brain metastases

Journal of Korean Neurosurgical Society

Volumn 52, Issue 3, 2012, Pages 193-199

  Jung, Jong myung ^a   Kim, Sohee ^b   Joo, Jungnam ^b   Kyung, Hwan Shin ^c   Gwak, Ho Shin ^d   Lee, Seung Hoon ^d  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul Korea Department of Radiation Oncology   (South Korea)

^c Neuro Oncology Clinic   (South Korea)

^d National Cancer Center   (South Korea)

Author keywords

Brain metastasis; Breast cancer; Leptomeningeal carcinomatosis; Surgery; Whole brain radiation therapy

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID CYTOLOGY; CONTROLLED STUDY; DISEASE COURSE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SYSTEMIC DISEASE;

EID: 84868298719     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2012.52.3.193     Document Type: Article

References (39)

1. Ahn JH, Lee SH, Kim S, Joo J, Yoo H, Lee SH, et al.: Risk for leptomen-ingeal seeding afer resection for brain metastases: implication of tumor location with mode of resection. J Neurosurg 116: 984-993, 2012
2. Bae JS, Yang SH, Yoon WS, Kang SG, Hong YK, Jeun SS: Te clinical features of spinal leptomeningeal dissemination from malignant glio-mas. J Korean Neurosurg Soc 49: 334-338, 2011
3. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE: Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22: 2865-2872, 2004
4. Beadle BM, Woodward WA, Buchholz TA: Te impact of age on outcome in early-stage breast cancer. Semin Radiat Oncol 21: 26-34, 2011
5. Chamberlain MC: Leptomeningeal metastasis. Curr Opin Oncol 22: 627-635, 2010
6. Cheng X, Hung MC: Breast cancer brain metastases. Cancer Metastasis Rev 26: 635-643, 2007
7. Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, et al.: Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 131: 1061-1066, 2012
8. DeAngelis LM: Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 38: 245-252, 1998
9. DeAngelis LM, Mandell LR, Taler HT, Kimmel DW, Galicich JH, Fuks Z, et al.: Te role of postoperative radiotherapy afer resection of single brain metastases. Neurosurgery 24: 798-805, 1989
10. Dosoretz DE, Blitzer PH, Russell AH, Wang CC: Management of solitary metastasis to the brain: the role of elective brain irradiation following complete surgical resection. Int J Radiat Oncol Biol Phys 6: 1727-1730, 1980
11. Fortner JG: Inadvertent spread of cancer at surgery. J Surg Oncol 53: 191-196, 1993
12. Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G: Epidemiology of meta-static brain tumors. Neurosurg Clin N Am 22: 1-6, v, 2011
13. Freilich RJ, Krol G, DeAngelis LM: Neuroimaging and cerebrospinal fuid cytology in the diagnosis of leptomeningeal metastasis. Ann Neu-rol 38: 51-57, 1995
14. Gauthier H, Guilhaume MN, Bidard FC, Pierga JY, Girre V, Cottu PH, et al.: Survival of breast cancer patients with meningeal carcinomatosis. Ann Oncol 21: 2183-2187, 2010
15. Glass JP, Melamed M, Chernik NL, Posner JB: Malignant cells in cere-brospinal fuid (CSF): the meaning of a positive CSF cytology. Neurology 29: 1369-1375, 1979
16. Grabb PA, Albright AL, Pang D: Dissemination of supratentorial malignant gliomas via the cerebrospinal fuid in children. Neurosurgery 30: 64-71, 1992
17. Kim HJ, Im SA, Keam B, Kim YJ, Han SW, Kim TM, et al.: Clinical outcome of central nervous system metastases from breast cancer: difer-ences in survival depending on systemic treatment. J Neurooncol 106: 303-313, 2012
18. Lee S, Ahn HK, Park YH, Nam do H, Lee JI, Park W, et al.: Leptomen-ingeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations. Breast Cancer Res Treat 129: 809-817, 2011
19. Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP: Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metas-tases. Cancer 113: 2638-2645, 2008
20. Lin NU, Winer EP: Brain metastases: the HER2 paradigm. Clin Cancer Res 13: 1648-1655, 2007
21. Mahajan A, Borden J, Tsai JS: Carcinomatous meningitis: are surgery-and gamma knife radiosurgery treatment risk factors? J Neurosurg 97: 441-444, 2002
22. Mayo WJ: Grafing and traumatic dissemination of carcinoma in the course of operations for malignant disease. JAMA 60: 512-513, 1913
23. Mirimanof RO, Choi NC: Intradural spinal metastases in patients with posterior fossa brain metastases from various primary cancers. Oncology 44: 232-236, 1987
24. Mirimanof RO, Choi NC: Te risk of intradural spinal metastases in patients with brain metastases from bronchogenic carcinomas. Int J Ra-diat Oncol Biol Phys 12: 2131-2136, 1986
25. Norris LK, Grossman SA, Olivi A: Neoplastic meningitis following surgical resection of isolated cerebellar metastasis: a potentially preventable complication. J Neurooncol 32: 215-223, 1997
26. Pace A, Fabi A: Chemotherapy in neoplastic meningitis. Crit Rev Oncol Hematol 60: 194-200, 2006
27. Patchell RA, Tibbs PA, Walsh J W, Dempsey RJ, Maruyama Y, Kryscio RJ, et al.: A randomized trial of surgery in the treatment of single me-tastases to the brain. N Engl J Med 322: 494-500, 1990
28. Pavlidis N: Te diagnostic and therapeutic management of leptomen-ingeal carcinomatosis. Ann Oncol 15 Suppl 4: iv285-iv291, 2004
29. Rosen ST, Aisner J, Makuch RW, Matthews MJ, Ihde DC, Whitacre M, et al.: Carcinomatous leptomeningitis in small cell lung cancer: a clini-copathologic review of the National Cancer Institute experience. Medicine (Baltimore) 61: 45-53, 1982
30. Seute T, Lefers P, ten Velde GP, Twijnstra A: Leptomeningeal metasta-ses from small cell lung carcinoma. Cancer 104: 1700-1705, 2005
31. Siomin VE, Vogelbaum MA, Kanner AA, Lee SY, Suh JH, Barnett GH: Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery. J Neurooncol 67: 115-121, 2004
32. Suki D, Abouassi H, Patel AJ, Sawaya R, Weinberg JS, Groves MD: Comparative risk of leptomeningeal disease afer resection or stereotac-tic radiosurgery for solid tumor metastasis to the posterior fossa. J Neu-rosurg 108: 248-257, 2008
33. Suki D, Hatiboglu MA, Patel AJ, Weinberg JS, Groves MD, Mahajan A, et al.: Comparative risk of leptomeningeal dissemination of cancer afer surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis. Neurosurgery 64: 664-674; discussion 674-676, 2009
34. Umpleby HC, Williamson RC: Anastomotic recurrence in large bowel cancer. Br J Surg 74: 873-878, 1987
35. van der Ree TC, Dippel DW, Avezaat CJ, Sillevis Smitt PA, Vecht CJ, van den Bent MJ: Leptomeningeal metastasis after surgical resection of brain metastases. J Neurol Neurosurg Psychiatry 66: 225-227, 1999
36. Waki F, Ando M, Takashima A, Yonemori K, Nokihara H, Miyake M, et al.: Prognostic factors and clinical outcomes in patients with leptomen-ingeal metastasis from solid tumors. J Neurooncol 93: 205-212, 2009
37. Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of lep-tomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49: 759-772, 1982
38. Yap HY, Yap BS, Tashima CK, DiStefano A, Blumenschein GR: Menin-geal carcinomatosis in breast cancer. Cancer 42: 283-286, 1978
39. Yildirim E, Dalgiç T, Berberoǧlu U: Prognostic signifcance of young age in breast cancer. J Surg Oncol 74: 267-272, 2000